The challenge now is not simply helping people live longer, but ensuring they age well.
Articles on HIV prevention
Displaying 1 - 20 of 53 articles
This week’s Pacific HIV Symposium in Fiji is a response to a highly complex regional crisis, not one that stops at the island nation’s border.
Alcohol use among adolescent girls and young women cannot be separated from transactional sex, coercion and violence in high HIV-burden settings.
Far from being simply glamorous or transactional, relationships with a “blesser” expose young women to risks.
Cabotegravir’s approval is the first time an alternative to oral Prep has been made available on the NHS.
Estimates are that one million HIV infections have been prevented, saving the cost of treating and monitoring those cases, and avoiding transmission to partners.
People are at the heart of the HIV pandemic, so it’s important to understand how they make protection decisions.
HIV expert Linda-Gail Bekker talks to The Conversation Weekly about promising results from a trial of a new drug for HIV prevention.
PrEP can reduce the risk of sexually transmitted HIV infection by 99%. Discrimination and distrust are two barriers Black gay men face in accessing this lifesaving treatment.
Despite higher than average rates of HIV infection, Hispanic women have relatively low awareness of PrEP, an effective HIV-prevention medication.
Funding announced in this week’s federal budget moves Australia closer to eliminating HIV.
Sex workers have a deep understanding of their needs but development partnerships tend to prioritise scientific knowledge.
Many people at heightened risk for HIV have never been tested. Those who have self-tested for HIV often don’t go on to receive care or change their sexual behavior.
The next step in HIV prevention — long-acting injectable pre-exposure prophylaxis (PrEP) — is not yet available in Canada, a year after its approval in the U.S.
The benefit of an injectable product is that it avoids the adherence issues related to taking a pill daily.
Some countries, like Kenya, Uganda, South Africa, Zambia, and Nigeria, have been more proactive than others, but it is still hard for many to get PrEP.
The omission of growing evidence that Māori, and Māori women in particular, have worse health outcomes after HIV infection could derail New Zealand’s elimination plans and exacerbate disparities.
PrEP enables adolescent girls and young women to protect themselves from HIV without having to convince a partner to use a condom at the time of sex.
Difficult to understand communication and the somewhat overstated benefits of male circumcision may lead to increased risky sexual behaviour.
Facebook began blocking ads that linked Truvada and other HIV-related drugs to severe bone and kidney damage based on claims made in lawsuits.
Top contributors
-
Professor of medicine and deputy director of the Desmond Tutu HIV Centre at the Institute of Infectious Disease and Molecular Medicine, University of Cape Town
-
Associate Professor, Public Health Ethics, School of Population Health, UNSW
-
Associate Professor and Director: Research at the Wits Reproductive Health and HIV Institute I, University of the Witwatersrand
-
Ezintsha, Faculty of Health Sciences, University of the Witwatersrand, University of the Witwatersrand
-
Assistant Professor of Public Health, University of Iowa
-
Director of Implementation Science, Wits Reproductive Health & HIV Institute, University of the Witwatersrand
-
Principal Research Fellow, Australian Research Centre in Sex, Health and Society, La Trobe University
-
Assistant Professor of Marketing Weber State University, Weber State University
-
Honorary Senior Lecturer, School of Public Health, University of Cape Town
-
Associate Professor of Psychology, Indiana University
-
PhD candidate, Ghent University
-
Extraordinary Professor in the Department of Medical Microbiology, University of Pretoria
-
Director: Child & Adolescent Health at the Wits Reproductive Health and HIV Institute, University of the Witwatersrand
-
Director: Clinical Trials, Wits Reproductive Health and HIV Institute, University of the Witwatersrand
-
Assistant Professor of Global Health, Boston University